Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Call Transcript May 17, 2024
Autolus Therapeutics plc misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.1.
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics’ Call to discuss its First Quarter 2024 Financial Results and Business Updates. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Olivia Manser. Please go...
